Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emil Lou

Showing results (21-30 of 184) with videos related to

Pageof 19
Sort By:
Annals of Translational Medicine|February 19, 2016
Integrating bevacizumab and radiation treatment of brain metastasis: is there sense and sensibility in this approach?Emil Lou, Paul W Sperduto
JAMA Oncology|July 10, 2020
Locally Advanced Rectal Cancer-Precision Therapy in a Time of Moving Targets and Competing GoalsRobert D Madoff, Emil Lou
Molecular Therapy. Oncology|February 24, 2026
Investigational CRISPR-Cas9-edited T cells for metastatic colorectal cancer treatment: Clinical insights for future developmentEmil Lou, Jasmine Foo, Kevin Leder
Molecular Therapy. Oncology|March 17, 2025
Senescence-associated secretory phenotype regulation by dual-drug delivery biomimetic nanoplatform for enhanced tumor chemotherapyAjay Prakash, Travis Gates, Emil Lou
Neuro-Oncology Practice|August 24, 2016
Temozolomide treatment of pituitary carcinomas and atypical adenomas: systematic review of case reportsYan Ji, Rachel Isaksson Vogel, Emil Lou
Cancer Biology & Therapy|August 20, 2019
Differential response of SHH-expressing adult medulloblastomas to the sonic hedgehog inhibitor vismodegib: whole-genome analysisEmil Lou, Andrew C Nelson, Marcel Kool
Journal of the National Comprehensive Cancer Network : JNCCN|April 14, 2017
Therapeutic Response of Metastatic Colorectal Cancer Harboring a <i>KRAS</i> Missense Mutation After Combination Chemotherapy With the EGFR Inhibitor PanitumumabEmil Lou, Donna D'Souza, Andrew C Nelson
Pancreas|October 25, 2013
Pancreatic cancer: modulation of KRAS, MicroRNAs, and intercellular communication in the setting of tumor heterogeneityEmil Lou, Subbaya Subramanian, Clifford J Steer
Mayo Clinic Proceedings|June 1, 2010
A potential novel variant of hereditary sensory neuropathy in a 61-year-old man with cough-induced syncope and vertebral artery dissectionEmil Lou, Stephan Züchner, Jeffery Vance, et al.
Molecular Therapy Oncolytics|July 26, 2021
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?Nuttavut Sumransub, Kornpong Vantanasiri, Ajay Prakash, et al.
Pageof 19

Showing results (21-30 of 184) with videos related to

Sort By:
Pageof 19
Annals of Translational Medicine|February 19, 2016
Integrating bevacizumab and radiation treatment of brain metastasis: is there sense and sensibility in this approach?Emil Lou, Paul W Sperduto
JAMA Oncology|July 10, 2020
Locally Advanced Rectal Cancer-Precision Therapy in a Time of Moving Targets and Competing GoalsRobert D Madoff, Emil Lou
Molecular Therapy. Oncology|February 24, 2026
Investigational CRISPR-Cas9-edited T cells for metastatic colorectal cancer treatment: Clinical insights for future developmentEmil Lou, Jasmine Foo, Kevin Leder
Molecular Therapy. Oncology|March 17, 2025
Senescence-associated secretory phenotype regulation by dual-drug delivery biomimetic nanoplatform for enhanced tumor chemotherapyAjay Prakash, Travis Gates, Emil Lou
Neuro-Oncology Practice|August 24, 2016
Temozolomide treatment of pituitary carcinomas and atypical adenomas: systematic review of case reportsYan Ji, Rachel Isaksson Vogel, Emil Lou
Cancer Biology & Therapy|August 20, 2019
Differential response of SHH-expressing adult medulloblastomas to the sonic hedgehog inhibitor vismodegib: whole-genome analysisEmil Lou, Andrew C Nelson, Marcel Kool
Journal of the National Comprehensive Cancer Network : JNCCN|April 14, 2017
Therapeutic Response of Metastatic Colorectal Cancer Harboring a <i>KRAS</i> Missense Mutation After Combination Chemotherapy With the EGFR Inhibitor PanitumumabEmil Lou, Donna D'Souza, Andrew C Nelson
Pancreas|October 25, 2013
Pancreatic cancer: modulation of KRAS, MicroRNAs, and intercellular communication in the setting of tumor heterogeneityEmil Lou, Subbaya Subramanian, Clifford J Steer
Mayo Clinic Proceedings|June 1, 2010
A potential novel variant of hereditary sensory neuropathy in a 61-year-old man with cough-induced syncope and vertebral artery dissectionEmil Lou, Stephan Züchner, Jeffery Vance, et al.
Molecular Therapy Oncolytics|July 26, 2021
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?Nuttavut Sumransub, Kornpong Vantanasiri, Ajay Prakash, et al.
Pageof 19